| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | Pazopanib | GDSC1000 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | -0.036 | 0.5 |
| mRNA | cyanoquinoline 11 | CTRPv2 | pan-cancer | AAC | 0.033 | 0.5 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.5 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | 0.047 | 0.5 |
| mRNA | VX-680 | GDSC1000 | pan-cancer | AAC | -0.036 | 0.5 |